These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 24704538)
1. Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. Singh D; Shrestha K; Testani JM; Verbrugge FH; Dupont M; Mullens W; Tang WH J Card Fail; 2014 Jun; 20(6):392-9. PubMed ID: 24704538 [TBL] [Abstract][Full Text] [Related]
2. First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization. Luk A; Groarke JD; Desai AS; Mahmood SS; Gopal DM; Joyce E; Shah SP; Lindenfeld J; Stevenson L; Lakdawala NK Am Heart J; 2018 Sep; 203():95-100. PubMed ID: 29907406 [TBL] [Abstract][Full Text] [Related]
3. Spot urine sodium-to-creatinine ratio surpasses sodium in identifying poor diuretic response in acute heart failure. Iwanek G; Guzik M; Zymliński R; Fudim M; Ponikowski P; Biegus J ESC Heart Fail; 2024 Oct; 11(5):3438-3442. PubMed ID: 38855817 [TBL] [Abstract][Full Text] [Related]
4. Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial. Palazzuoli A; Pellegrini M; Ruocco G; Martini G; Franci B; Campagna MS; Gilleman M; Nuti R; McCullough PA; Ronco C Crit Care; 2014 Jun; 18(3):R134. PubMed ID: 24974232 [TBL] [Abstract][Full Text] [Related]
5. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [TBL] [Abstract][Full Text] [Related]
6. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. Thomson MR; Nappi JM; Dunn SP; Hollis IB; Rodgers JE; Van Bakel AB J Card Fail; 2010 Mar; 16(3):188-93. PubMed ID: 20206891 [TBL] [Abstract][Full Text] [Related]
7. Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure. Testani JM; Hanberg JS; Cheng S; Rao V; Onyebeke C; Laur O; Kula A; Chen M; Wilson FP; Darlington A; Bellumkonda L; Jacoby D; Tang WH; Parikh CR Circ Heart Fail; 2016 Jan; 9(1):e002370. PubMed ID: 26721915 [TBL] [Abstract][Full Text] [Related]
8. Serial assessment of spot urine sodium predicts effectiveness of decongestion and outcome in patients with acute heart failure. Biegus J; Zymliński R; Sokolski M; Todd J; Cotter G; Metra M; Jankowska EA; Banasiak W; Ponikowski P Eur J Heart Fail; 2019 May; 21(5):624-633. PubMed ID: 30773755 [TBL] [Abstract][Full Text] [Related]
9. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure. Shah RV; McNulty S; O'Connor CM; Felker GM; Braunwald E; Givertz MM Am Heart J; 2012 Dec; 164(6):862-8. PubMed ID: 23194486 [TBL] [Abstract][Full Text] [Related]
10. Spot urinary sodium in acute decompensation of advanced heart failure and dilutional hyponatremia: insights from DRAIN trial. Galluzzo A; Frea S; Boretto P; Pidello S; Volpe A; Canavosio FG; Golzio PG; Bergerone S; De Ferrari GM Clin Res Cardiol; 2020 Oct; 109(10):1251-1259. PubMed ID: 32144493 [TBL] [Abstract][Full Text] [Related]
15. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide. Kurien S; Warfield KT; Wood CM; Miller WL Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223 [TBL] [Abstract][Full Text] [Related]
16. Potential Role of Natriuretic Response to Furosemide Stress Test During Acute Heart Failure. Caravaca Pérez P; Nuche J; Morán Fernández L; Lora D; Blázquez-Bermejo Z; López-Azor JC; de Juan Bagudá J; García-Cosío Carmena MD; Escribano Subías P; Salguero-Bodes R; Arribas Ynsaurriaga F; Delgado JF Circ Heart Fail; 2021 Jun; 14(6):e008166. PubMed ID: 34129364 [TBL] [Abstract][Full Text] [Related]
17. Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction. Zheng Z; Jiang X; Chen J; He D; Xie X; Lu Y ESC Heart Fail; 2021 Jun; 8(3):2070-2078. PubMed ID: 33689236 [TBL] [Abstract][Full Text] [Related]